Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

por Wada, Yuina, Maekawa, Motoko, Ohnishi, Tetsuo, Balan, Shabeesh, Matsuoka, Shigeru, Iwamoto, Kazuya, Iwayama, Yoshimi, Ohba, Hisako, Watanabe, Akiko, Hisano, Yasuko, Nozaki, Yayoi, Toyota, Tomoko, Shimogori, Tomomi, Itokawa, Masanari, Kobayashi, Tetsuyuki, Yoshikawa, Takeo
Publicado 2020

A potential role of fatty acid binding protein 4 in the pathophysiology of autism spectrum disorder

por Maekawa, Motoko, Ohnishi, Tetsuo, Toyoshima, Manabu, Shimamoto-Mitsuyama, Chie, Hamazaki, Kei, Balan, Shabeesh, Wada, Yuina, Esaki, Kayoko, Takagai, Shu, Tsuchiya, Kenji J, Nakamura, Kazuhiko, Iwata, Yasuhide, Nara, Takahiro, Iwayama, Yoshimi, Toyota, Tomoko, Nozaki, Yayoi, Ohba, Hisako, Watanabe, Akiko, Hisano, Yasuko, Matsuoka, Shigeru, Tsujii, Masatsugu, Mori, Norio, Matsuzaki, Hideo, Yoshikawa, Takeo
Publicado 2020

Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology

por Ide, Masayuki, Ohnishi, Tetsuo, Toyoshima, Manabu, Balan, Shabeesh, Maekawa, Motoko, Shimamoto‐Mitsuyama, Chie, Iwayama, Yoshimi, Ohba, Hisako, Watanabe, Akiko, Ishii, Takashi, Shibuya, Norihiro, Kimura, Yuka, Hisano, Yasuko, Murata, Yui, Hara, Tomonori, Morikawa, Momo, Hashimoto, Kenji, Nozaki, Yayoi, Toyota, Tomoko, Wada, Yuina, Tanaka, Yosuke, Kato, Tadafumi, Nishi, Akinori, Fujisawa, Shigeyoshi, Okano, Hideyuki, Itokawa, Masanari, Hirokawa, Nobutaka, Kunii, Yasuto, Kakita, Akiyoshi, Yabe, Hirooki, Iwamoto, Kazuya, Meno, Kohji, Katagiri, Takuya, Dean, Brian, Uchida, Kazuhiko, Kimura, Hideo, Yoshikawa, Takeo
Publicado 2019